NASA/Lewis Research Center, 21000 Brookpark Road, Cleveland, OH 44135

A -- NON PERSONAL SERVICES ENTITLED "CHARACTERIZING DIABETIC VITREOPATHY BY DYNAMIC LIGHT SCATTERING SOL RFQ-099318 DUE 042998 POC Kathleen A. Webb, Purchasing Agent, Phone (216) 433-6665, Fax (216) 433-2480, Email Kathleen.A.Webb@lerc.nasa.gov WEB: Click here for the latest information about this notice, http://nais.nasa.gov/EPS/LeRC/date.html#RFQ-099318. E-MAIL: Kathleen A. Webb, Kathleen.A.Webb@lerc.nasa.gov. NASA/LeRC plans to issue a Request for Quotation (RFQ) for NON-PERSONAL SERVICES FOR DR. JERRY SEBAG ENTITLED "CHARACTERIZING DIABETIC VITREOPATHY BY DYNAMIC LIGHT SCATTERING". This procurement is being conducted under the Simplified Acquisition Procedures (SAP). NASA/LeRC intends to purchase SERVICES FROM DR. JERRY SEBAG. IDENTIFY THE SOLE SOURCE, THE AUTHORITY FOR OTHER THAN FULL AND OPEN COMPETITION AND A STATEMENT JUSTIFYING LACK OF COMPETITION]. DR. JERRY SEBAG IS AN OUTSTANDING SURGEON/PHYSICIAN AND A LEADING AUTHORITY IN THE WORLD OF THE VITREOUS HUMOR OF THE EYE. HE HAS AUTHORED A VERY COMPREHENSIVE BOOK AND NUMEROUS PAPERS ON THE VITREOUS HUMOR. DR. SEBAG IS UNIQUELY QUALIFIED TO CONDUCT THE WORK REQUIRED IN THE STATEMENT OF WORK CONTAINED HEREIN FOR THE FOLLLOWING REASONS: 1. FAMILIARITY WITH THE TECHNIQUES INVOLVED IN THE OPERATION OF THE DYNAMIC LIGHT SCATTERING EYE DIAGNOSTIC DEVICE (INVENTED BY DR. RAFAT ANSARI OF NASA/NCMR) USED FOR THE EARLY DETECTION OF CATARACTS AND OTHER EYE DISEASESSUCH AS DIABETIC RENTINOPATHY. 2. ACCOMPLISHMENTS AND EXPERTISE IN THE DIAGNOSIS, DETECTION, TREATMENT AND MOLECULAR MORPHOLOGY OF EYE DISEASES OF THE VITREOUS HUMOR. 3. PREVIOUS WORK USING AUTOPSIED HUMAN EYES FOR CHARACTERIZATION OF THE VITREOUS USING THE NASA DYNAMIC LIGHT SCATTERING EYE DIAGNOSTIC DEVICE. 4. QUALIFIED TO PERFORM HUMAN AND ANIMAL TISSUE INVESTIGATIONS ACCORDING TO THE NATIONAL INSTITUTE GUIDELINES. THERE WILL BE LIVE ANIMAL EXPERIMENTATION PERFORMED IN THE ACCOMPLISHMENT OF THIS INVESTIGATION. THESE ANIMALS HAVE BEEN GENETICALLY ENGINEERED FOR MEDICAL STUDIES OF THE DIABETIC CONDITION. ALL TESTING WILL BE PERFORMED HUMANELY, BY QUALIFIED AND LICENSED MEDICAL PROFESSIONALS AND TECHNICIANS. The Government does not intend to acquire a commercial item using FAR Part 12. See Note 26. Any referenced notes can be viewed at the following URL: http://genesis.gsfc.nasa.gov/nnotes.htm. Interested firms have FIFTEEN (15) days from the publication of this synopsis to submit in writing to the identified point of contact, their qualifications/capabilities. Such qualifications/capabilities will be used solely for the purpose of determining whether or not to conduct this procurement on a competitive basis. Responses received after the FIFTEEN (15) days or without the required information will be considered nonresponsive to the synopsis and will not be considered. A determination by the Government to not compete this proposed effort on a full and open competitive basis, based upon responses to this notice is solely within the discretion of the Government. Oral communications are not acceptable in response to this notice. All responsible sources may submit an offer which shall be considered by the agency. OMBUDSMAN STATEMENT REQUIRED] An Ombudsman has been appointed. See Internet Note "B". (0104)

Loren Data Corp. http://www.ld.com (SYN# 0002 19980417\A-0002.SOL)